RGEN vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

RGEN

49.4
AI Score
VS
RGEN Wins

XRAY

43.0
AI Score

Investment Advisor Scores

RGEN

49score
Recommendation
HOLD

XRAY

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RGEN XRAY Winner
Revenue 44.83M 2.61B XRAY
Net Income 3.45M 25.00M XRAY
Gross Margin 56.1% 52.1% RGEN
Net Margin 7.7% 1.0% RGEN
Operating Income 5.98M 84.00M XRAY
ROE 0.6% 1.8% XRAY
ROA 0.5% 0.5% XRAY
Total Assets 743.25M 5.19B XRAY
Cash 173.88M 195.00M XRAY
Current Ratio 12.22 1.63 RGEN

Relative Price Performance (Last 90 Days)

RGEN 1M: -1.6% · 3M: +3.1% XRAY 1M: +14.8% · 3M: -15.7%

Current Technical Phase

RGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.7 · Price: $172.62

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $9.76

Fundamentals Snapshot

Metric RGEN XRAY
Market Cap — —
Forward P/E 65.1 7.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.5% 0.5%
Operating Margin 0.1% 0.0%
EPS -0.21 -0.61
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, RGEN is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.